275 related articles for article (PubMed ID: 15128773)
41. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts.
O'Connell PJ; Li W; Wang Z; Specht SM; Logar AJ; Thomson AW
J Immunol; 2002 Jan; 168(1):143-54. PubMed ID: 11751957
[TBL] [Abstract][Full Text] [Related]
42. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
Bauman SK; Nichols KL; Murphy JW
J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
[TBL] [Abstract][Full Text] [Related]
43. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
Han WR; Murray-Segal LJ; Mottram PL
Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
[TBL] [Abstract][Full Text] [Related]
44. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival.
Garrod KR; Chang CK; Liu FC; Brennan TV; Foster RD; Kang SM
J Immunol; 2006 Jul; 177(2):863-8. PubMed ID: 16818740
[TBL] [Abstract][Full Text] [Related]
45. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
46. CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice.
Colvin BL; Wang Z; Nakano H; Wu W; Kakiuchi T; Fairchild RL; Thomson AW
Am J Transplant; 2005 Sep; 5(9):2104-13. PubMed ID: 16095489
[TBL] [Abstract][Full Text] [Related]
47. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
48. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice.
Masten BJ; Olson GK; Kusewitt DF; Lipscomb MF
J Immunol; 2004 Apr; 172(7):4077-83. PubMed ID: 15034019
[TBL] [Abstract][Full Text] [Related]
49. The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.
Fernandes E; Goold HD; Kissenpfennig A; Malissen B; Dyson J; Bennett CL
Transplantation; 2011 Jan; 91(2):154-60. PubMed ID: 21085063
[TBL] [Abstract][Full Text] [Related]
50. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
[TBL] [Abstract][Full Text] [Related]
51. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
52. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
[TBL] [Abstract][Full Text] [Related]
53. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
[TBL] [Abstract][Full Text] [Related]
54. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
55. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
56. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
57. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.
Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS
J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132
[TBL] [Abstract][Full Text] [Related]
58. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
59. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity.
Steptoe RJ; Fu F; Li W; Drakes ML; Lu L; Demetris AJ; Qian S; McKenna HJ; Thomson AW
J Immunol; 1997 Dec; 159(11):5483-91. PubMed ID: 9548488
[TBL] [Abstract][Full Text] [Related]
60. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.
Szot GL; Zhou P; Sharpe AH; He G; Kim O; Newell KA; Bluestone JA; Thistlethwaite JR
Transplantation; 2000 Mar; 69(5):904-9. PubMed ID: 10755548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
